SCHEMBL6322927

SCHEMBL6322927

CC(CC(c1ccc(O)cc1)c1ccc(O)cc1)N(Cc1ccccc1)C[C@H](O)CS(=O)(=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.38
ALDH1A1 P00352 1/20 0.36
HSD11B1 P28845 1/20 0.36
OPRK1 P41145 4/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
ADRA1A P35348 2/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
LMNA P02545 1/20 0.35
ADRB2 P07550 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2A P28223 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322935 1.00 ESR1 (0.38) ESR1ALDH1A1HSD11B1OPRK1CYP1A2
SCHEMBL6323872 0.81 ADRA1A (0.49) OPRK1CYP1A2CYP2C19ADRA1ALMNA
SCHEMBL6320874 0.78 BACE1 (0.41) ALDH1A1OPRK1CYP1A2CYP2C19ADRA1A
SCHEMBL6320867 0.78 BACE1 (0.41) ALDH1A1OPRK1CYP1A2CYP2C19ADRA1A
Hydrochloric Acid SCHEMBL6328295 0.73 ADRA1A (0.39) HSD11B1OPRK1CYP1A2CYP2C19ADRA1A
Hydrochloric Acid SCHEMBL6328292 0.73 ADRA1A (0.39) HSD11B1OPRK1CYP1A2CYP2C19ADRA1A
Hydrochloric Acid SCHEMBL6320397 0.67 POLB (0.53) ESR1ALDH1A1CYP1A2CYP2C19ADRA1A
Hydrochloric Acid SCHEMBL6327403 0.67 POLB (0.53) ESR1ALDH1A1CYP1A2CYP2C19ADRA1A
SCHEMBL6642402 0.66 ALDH1A1 (0.52) ALDH1A1OPRK1ADRA1AGAAADRA2B
SCHEMBL6642397 0.65 ALDH1A1 (0.51) ALDH1A1OPRK1ADRA1AGAAADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043371-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-02-24 US disclosed
US-20030181726-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043371-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB3, ADRB2 ESR1 3038/4885ALDH1A1 197/4885HSD11B1 667/4885
US-20030181726-A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists ADRB1, ADRB3, ADRB2 ESR1 3388/4885ALDH1A1 183/4885HSD11B1 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.